Viewing Study NCT04160494


Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2026-03-08 @ 12:50 AM
Study NCT ID: NCT04160494
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-11
First Post: 2019-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: D2C7-IT With Atezolizumab for Recurrent Gliomas
Sponsor: Darell Bigner
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module